Papillary and follicular thyroid cancer: impact of treatment in 1578 patients

Journal Article · Wed Jun 01 00:00:00 EDT 1988 · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

DOI:https://doi.org/10.1016/0360-3016(88)90381-1· OSTI ID:6908499

Simpson, W J; Panzarella, T; Carruthers, J S; Gospodarowicz, M K; Sutcliffe, S B

We report the experience from 13 Canadian radiotherapy centers concerning the treatment and outcome for 1074 papillary and 504 follicular thyroid cancer patients followed for 4-24 years. Surgical resection was carried out in almost all patients; there was no correlation between the type of operation and recurrence or survival. Treatment with external irradiation (201 patients) radioiodine (214 patients), or both (107 patients) was used more often in poor prognosis patients than in those with good prognostic factors, and was effective in reducing local recurrences and improving survival, especially in patients with microscopic residual disease postoperatively. Treatment complications were common but rarely fatal. Thyroid cancer was the cause of death in over half of the papillary cancer deaths and in two-thirds of the follicular cancer deaths.

• Research Organization: Princess Margaret Hospital, Toronto, Ontario (Canada)
• OSTI ID: 6908499
• Journal Information: Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 14:6
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
NEOPLASMS
RADIOTHERAPY
THYROID
CANADA
PATIENTS
SURVIVAL CURVES
THYROIDECTOMY
BODY
DISEASES
ENDOCRINE GLANDS
GLANDS
MEDICINE
NORTH AMERICA
NUCLEAR MEDICINE
ORGANS
RADIOLOGY
SURGERY
THERAPY
550603* - Medicine- External Radiation in Therapy- (1980-)
550604 - Medicine- Unsealed Radionuclides in Therapy- (1980-)
550600 - Medicine